{"id":"https://openalex.org/W7106318656","doi":"https://doi.org/10.1093/jimmun/vkaf283.093","title":"Alterations of Ceramide Synthesis Induce PD-L1 Internalization and Signaling to Regulate Tumor Metastasis and Immunotherapy Response 2131","display_name":"Alterations of Ceramide Synthesis Induce PD-L1 Internalization and Signaling to Regulate Tumor Metastasis and Immunotherapy Response 2131","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W7106318656","doi":"https://doi.org/10.1093/jimmun/vkaf283.093"},"language":"en","primary_location":{"id":"doi:10.1093/jimmun/vkaf283.093","doi":"https://doi.org/10.1093/jimmun/vkaf283.093","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jimmun/vkaf283.093","pdf_url":"https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.093/65413621/vkaf283.093.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.093/65413621/vkaf283.093.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Besim Ogretmen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]},{"id":"https://openalex.org/I4210095449","display_name":"MUSC Hollings Cancer Center","ror":"https://ror.org/00w52vt71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095449"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Besim Ogretmen","raw_affiliation_strings":["Hollings Cancer Center, Medical University of South Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hollings Cancer Center, Medical University of South Carolina","institution_ids":["https://openalex.org/I153297377","https://openalex.org/I4210095449"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I153297377","https://openalex.org/I4210095449"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.44877398,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"214","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8920999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8920999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.10339999943971634,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceramide-synthesis","display_name":"ceramide synthesis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/sonic-hedgehog-signaling","display_name":"Sonic hedgehog signaling","score":0.9520000219345093},{"id":"https://openalex.org/keywords/tgf-beta-receptor-signaling","display_name":"TGF-beta receptor signaling","score":0.8569999933242798},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.7979999780654907},{"id":"https://openalex.org/keywords/caprin1","display_name":"CAPRIN1","score":0.8240000009536743},{"id":"https://openalex.org/keywords/mrna-stabilization","display_name":"mRNA stabilization","score":0.7850000262260437},{"id":"https://openalex.org/keywords/beta-catenin-signaling","display_name":"\u03b2-catenin signaling","score":0.9369999766349792},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9879999756813049},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.9390000104904175},{"id":"https://openalex.org/keywords/foxp3-regulatory-t-cells","display_name":"Foxp3+ regulatory T cells","score":0.7919999957084656},{"id":"https://openalex.org/keywords/sonidegib","display_name":"sonidegib","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.887499988079071},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7351999878883362},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7105000019073486},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5666999816894531},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5594000220298767},{"id":"https://openalex.org/C2777851122","wikidata":"https://www.wikidata.org/wiki/Q424213","display_name":"Ceramide","level":3,"score":0.5437999963760376},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5333999991416931},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4726000130176544},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.4699000120162964},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.41499999165534973},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37209999561309814},{"id":"https://openalex.org/C150555746","wikidata":"https://www.wikidata.org/wiki/Q210973","display_name":"Cell signaling","level":3,"score":0.36469998955726624},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3578999936580658},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.352400004863739},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3465999960899353},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.33889999985694885},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.3379000127315521},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3327000141143799},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.32179999351501465},{"id":"https://openalex.org/C2776187077","wikidata":"https://www.wikidata.org/wiki/Q1888235","display_name":"Mammary tumor","level":4,"score":0.29010000824928284},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2818000018596649},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2777000069618225},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.26269999146461487},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.260699987411499}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/jimmun/vkaf283.093","doi":"https://doi.org/10.1093/jimmun/vkaf283.093","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jimmun/vkaf283.093","pdf_url":"https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.093/65413621/vkaf283.093.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/jimmun/vkaf283.093","doi":"https://doi.org/10.1093/jimmun/vkaf283.093","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jimmun/vkaf283.093","pdf_url":"https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.093/65413621/vkaf283.093.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4216714955","display_name":"Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling","funder_award_id":"P01CA203628","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000183288","display_name":null,"funder_award_id":"CA203628","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000878829","display_name":"Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy","funder_award_id":"R01DE016572","funder_id":"https://openalex.org/F4320337365","funder_display_name":"National Institute of Dental and Craniofacial Research"},{"id":"https://openalex.org/G9000918851","display_name":"Ceramide metabolism and the regulation of PD-L1 signaling to control metastasis and resistance to immunotherapy in TNBC","funder_award_id":"R01CA214461","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309737","display_name":"Fondation pour l'Aide \u00e0 la Recherche sur la Scl\u00e9rose en Plaques","ror":"https://ror.org/04gyrp304"},{"id":"https://openalex.org/F4320320893","display_name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","ror":"https://ror.org/02vjkv261"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337365","display_name":"National Institute of Dental and Craniofacial Research","ror":"https://ror.org/004a2wv92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7106318656.pdf","grobid_xml":"https://content.openalex.org/works/W7106318656.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400924158","https://openalex.org/W4393075778","https://openalex.org/W4409624267","https://openalex.org/W7149012852","https://openalex.org/W7140862651","https://openalex.org/W3152567134","https://openalex.org/W3193173701","https://openalex.org/W2799522453","https://openalex.org/W2988353924","https://openalex.org/W4385688136"],"abstract_inverted_index":{"Abstract":[0],"Description":[1],"Programmed":[2],"death-ligand":[3],"1,":[4],"PD-L1":[5,25,63,122,166,184],"(CD274)":[6],"facilitates":[7],"immune":[8,129],"evasion":[9],"and":[10,42,78,89,108,115,124,137,153,163,208,219],"exerts":[11],"pro-survival":[12],"functions":[13],"in":[14,26,50,97,134,148,168,172,179,189],"cancer":[15],"cells.":[16],"Here,":[17],"we":[18],"report":[19],"a":[20,140],"mechanism":[21],"whereby":[22],"internalization":[23,123],"of":[24,30,85,121,160,182,204],"response":[27],"to":[28,46,70,74,91,144,174,211],"alterations":[29],"bioactive":[31],"lipid/ceramide":[32],"metabolism":[33],"by":[34,197],"ceramide":[35],"synthase":[36],"4":[37],"(CerS4)":[38],"induces":[39],"sonic-hedgehog":[40],"(Shh)":[41],"TGF-b":[43],"receptor":[44],"signaling":[45,77,167,185],"enhance":[47],"tumor":[48,113],"metastasis":[49],"triple-negative":[51],"breast":[52],"cancers":[53],"(TNBC),":[54],"exhibiting":[55],"immunotherapy":[56,146,178],"resistance.":[57],"Mechanistically,":[58],"data":[59,155],"showed":[60],"that":[61,158],"internalized":[62],"interacts":[64],"with":[65,82,118],"an":[66],"RNA-binding":[67],"protein":[68],"Caprin-1":[69],"stabilize":[71],"Shh/TGFBR1/Wnt":[72],"mRNAs":[73],"induce":[75],"b-catenin":[76],"TNBC":[79,169],"growth/metastasis,":[80],"consistent":[81,117],"increased":[83,164],"infiltration":[84],"FoxP3+":[86],"T":[87],"regs":[88],"resistance":[90,173],"immunotherapy.":[92],"While":[93],"mammary":[94],"tumors":[95,170],"developed":[96],"MMTV-PyMT/CerS4-/-":[98],"were":[99],"highly":[100],"metastatic,":[101],"targeting":[102],"the":[103,119,201],"Shh/PD-L1":[104],"axis":[105],"using":[106],"Sonidegib":[107],"anti-PD-L1":[109],"antibody":[110],"vastly":[111],"decreased":[112],"growth":[114],"metastasis,":[116],"inhibition":[120],"Shh/Wnt":[125],"signaling,":[126],"restoring":[127],"anti-tumor":[128],"response.":[130],"These":[131],"data,":[132],"validated":[133],"clinical":[135],"samples":[136],"databases,":[138],"provide":[139],"mechanism-based":[141],"therapeutic":[142],"strategy":[143],"improve":[145],"responses":[147],"metastatic":[149],"TNBCs.":[150,180],"Our":[151],"recent":[152],"unpublished":[154],"also":[156],"revealed":[157],"attenuation":[159],"CerS4":[161],"expression":[162],"intracellular":[165,183],"result":[171],"anti-PD-1":[175],"or":[176],"anti-PD-L1-based":[177],"Inhibition":[181],"resensitized":[186],"resistant":[187],"TNBCs":[188],"vivo.":[190],"Funding":[191],"Sources":[192],"This":[193],"work":[194],"was":[195],"supported":[196],"research":[198],"funding":[199],"from":[200],"National":[202],"Institutes":[203],"Health":[205],"(CA214461,":[206],"DE016572,":[207],"P01":[209],"CA203628":[210],"BO).":[212],"Topic":[213],"Categories":[214],"Tumor":[215],"Immunology:":[216],"Checkpoints,":[217],"Prevention,":[218],"Treatment":[220],"(TIPT)":[221]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-11-23T00:00:00"}